A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP

Clinical trial NCT03988920 · COMPLETED

Trial details

NCT number: NCT03988920
Sponsor: Ardelyx
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hyperphosphatemia End Stage Renal Disease

Start date: 2019-06-15
Primary completion: 2021-06-26
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.